# Safety and Efficacy Study of Microplasmin in for Non-Surgical Treatment of Focal Vitreomacular Adhesion

> **NCT01055535** · PHASE2 · COMPLETED · sponsor: **ThromboGenics** · enrollment: 17 (actual)

## Conditions studied

- Focal Vitreomacular Adhesion

## Interventions

- **DRUG:** Microplasmin

## Key facts

- **NCT ID:** NCT01055535
- **Lead sponsor:** ThromboGenics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2014-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01055535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01055535, "Safety and Efficacy Study of Microplasmin in for Non-Surgical Treatment of Focal Vitreomacular Adhesion". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01055535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*